Details of the Drug

General Information of Drug (ID: DMAZAGJ)

Drug Name

SO-C101

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Recombinant protein

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04234113) Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors. U.S. National Institutes of Health.